Charles McWherter

Dr. McWherter has served as the Chief Scientific Officer and President of Research and Development since November 2022. Previously he served as the Chief Scientific Officer since 2013. From 2007 to 2013 he served as our Senior Vice President, Research and Preclinical Development and from 2003 to 2007, he served as Vice President and head of the cardiovascular therapeutics areas of Pfizer Inc. From 2001 to 2003, Dr. McWherter served as Vice President of Drug Discovery at Sugen, Inc., a subsidiary of Pharmacia acquired by Pfizer Inc. in 2003. Dr. McWherter was a Visiting Scientist at the Weizmann Institute of Science in Israel and obtained his Ph.D. in Biophysical Chemistry from Cornell University.